Skip to content
Home/Companies/HealthTech/Abcodia

Abcodia

HealthTech·UK·Exited 2022·Held 7yr
Entry
2015
Hold
7yr
Exit
2022

Who owns Abcodia?

Abcodia is a British HealthTech company, now owned by GENinCode, which acquired it in 2022 from Cambridge Innovation Capital.

Hand-verified · updated 2026-07-08

Open JSON · CC-BY
Cambridge Innovation Capital
Investor
Cambridge Innovation Capital
CIC Fund I · 2013 · VC

Key facts

HQUK
SectorHealthTech
StatusAcquired
Exit Type
Trade Sale
Buyer
GENinCode
Exit Year
2022

More from CIC Fund I

Other portfolio companies in the same fund.

Seldon
Seldon
Exited 2026
AI/MLUK· 2020
to TrueFoundry
Gyroscope Therapeutics
Gyroscope Therapeutics
Exited 2021
BiotechUK· 2019
to Novartis
PredictImmune
Exited 2024
HealthTechUK· 2019
Sense Biodetection
Sense Biodetection
Exited 2023
MedTechUK· 2019
to Sherlock Biosciences
Audio Analytic
Exited 2022
AI/MLUK· 2017
to Meta
Cytora
Cytora
Exited 2025
InsurTechUK· 2017
to Applied Systems

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Abcodia?

Abcodia is now owned by GENinCode, which acquired it in 2022 from Cambridge Innovation Capital.

When did GENinCode acquire Abcodia?

GENinCode acquired Abcodia in 2022, buying from Cambridge Innovation Capital.

Who did Abcodia sell to?

Cambridge Innovation Capital sold Abcodia to GENinCode in 2022 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue